Total Payments
$8,912
2024 Payments
$1,567
Companies
36
Transactions
273
Medicare Patients
11,606
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$7,703 (86.4%)
Travel$1,209 (13.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,703 | 268 | 86.4% |
| Travel and Lodging | $1,209 | 5 | 13.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,435 | 24 | $0 (2024) |
| Shockwave Medical, Inc | $1,058 | 18 | $0 (2022) |
| Medtronic Vascular, Inc. | $867.10 | 5 | $0 (2019) |
| Boston Scientific Corporation | $604.34 | 30 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $497.76 | 19 | $0 (2024) |
| CVRx, Inc. | $435.91 | 5 | $0 (2022) |
| ABIOMED | $394.08 | 9 | $0 (2024) |
| Medtronic, Inc. | $356.06 | 6 | $0 (2023) |
| Abbott Laboratories | $348.41 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $332.02 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,567 | 77 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($174.34) |
| 2023 | $1,976 | 88 | Boehringer Ingelheim Pharmaceuticals, Inc. ($259.65) |
| 2022 | $1,506 | 38 | Shockwave Medical, Inc ($618.50) |
| 2021 | $825.39 | 22 | Shockwave Medical, Inc ($367.04) |
| 2020 | $299.10 | 6 | Boston Scientific Corporation ($166.75) |
| 2019 | $364.47 | 12 | Edwards Lifesciences Corporation ($143.33) |
| 2018 | $2,050 | 20 | Edwards Lifesciences Corporation ($923.93) |
| 2017 | $324.82 | 10 | ABIOMED ($171.90) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $26.52 | General |
| Category: Cardiovascular | ||||||
| 11/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $29.68 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Genetic Disease | ||||||
| 11/06/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $91.91 | General |
| Category: Heart Failure | ||||||
| 10/16/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: EMBLEM_CRM | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/08/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/03/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $23.46 | General |
| Category: Coronary | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Transcatheter Heart Valves | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Genetic Disease | ||||||
| 09/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $37.42 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Transcatheter Heart Valves | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $14.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $28.39 | General |
| Category: Peripheral Intervention | ||||||
| 08/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 50 | 4,945 | 7,205 | $2.5M | $605,375 |
| 2022 | 37 | 2,834 | 4,175 | $1.9M | $371,747 |
| 2021 | 31 | 2,167 | 3,283 | $1.5M | $317,884 |
| 2020 | 27 | 1,660 | 2,628 | $1.2M | $247,857 |
Total Patients
11,606
Total Services
17,291
Medicare Billing
$1.5M
Procedure Codes
157
All Medicare Procedures & Services
157 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 632 | 986 | $300,730 | $107,782 | 35.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 346 | 354 | $325,326 | $69,363 | 21.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 136 | 138 | $330,234 | $63,811 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 223 | 335 | $136,010 | $53,339 | 39.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 115 | 433 | $59,754 | $33,824 | 56.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 148 | 385 | $85,470 | $26,921 | 31.5% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 37 | 37 | $137,233 | $22,887 | 16.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 133 | 526 | $140,968 | $20,320 | 14.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 136 | 264 | $137,412 | $18,679 | 13.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 129 | 129 | $59,469 | $18,319 | 30.8% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 66 | 66 | $59,202 | $15,435 | 26.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 62 | 63 | $57,645 | $13,090 | 22.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 201 | 212 | $48,972 | $12,593 | 25.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 75 | 75 | $43,875 | $11,467 | 26.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 65 | 102 | $35,394 | $10,758 | 30.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 22 | 22 | $74,778 | $10,177 | 13.6% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 105 | 398 | $33,034 | $8,833 | 26.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 506 | 580 | $61,480 | $7,432 | 12.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 38 | $26,828 | $7,035 | 26.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 34 | 34 | $27,370 | $6,809 | 24.9% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 33 | 33 | $24,816 | $5,528 | 22.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 639 | 753 | $19,578 | $4,954 | 25.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 19 | 19 | $18,487 | $4,829 | 26.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 76 | 78 | $34,320 | $4,755 | 13.9% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 14 | 14 | $14,462 | $3,866 | 26.7% |
About Dr. Ryan Brown, MD
Dr. Ryan Brown, MD is a Internal Medicine healthcare provider based in Walnut Creek, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467425439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Brown, MD has received a total of $8,912 in payments from pharmaceutical and medical device companies, with $1,567 received in 2024. These payments were reported across 273 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,703).
As a Medicare-enrolled provider, Brown has provided services to 11,606 Medicare beneficiaries, totaling 17,291 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 157 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Interventional Cardiology, Nuclear Cardiology
- Location Walnut Creek, CA
- Active Since 02/09/2006
- Last Updated 11/08/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1467425439
Products in Payments
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,067
- CoreValve Evolut (Device) $850.35
- LifeVest (Device) $497.76
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $484.68
- Barostim Neo System (Device) $435.91
- Impella (Device) $394.08
- Vascular Lithotripsy (Device) $391.87
- JARDIANCE (Drug) $316.94
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $272.60
- 3F (Device) $218.66
- Arcalyst (Drug) $197.55
- XARELTO (Drug) $191.31
- CAMZYOS (Drug) $169.49
- GENERAL - STRUCTURAL HEART (Device) $166.75
- COREVALVE EVOLUT R (Device) $154.15
- VERQUVO (Drug) $152.14
- ELIQUIS (Drug) $150.55
- LEQVIO (Drug) $144.81
- FARXIGA (Drug) $143.50
- CARDIOMEMS (Device) $127.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Walnut Creek
Anthony Padula, M.d, M.D
Internal Medicine — Payments: $804,141
Internal Medicine $804,141
Dr. Richard Chang, M.d, M.D
Internal Medicine — Payments: $295,804
Internal Medicine $295,804
Dr. Neal White, Md, MD
Internal Medicine — Payments: $224,225
Internal Medicine $224,225
Dr. Aditi Choudhry, M.d, M.D
Internal Medicine — Payments: $69,819
Internal Medicine $69,819
Dr. Andrew Dublin, Md, MD
Internal Medicine — Payments: $65,190
Internal Medicine $65,190
Dr. Bhavna Malik, Md, MD
Internal Medicine — Payments: $39,855
Internal Medicine $39,855